These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1015906)

  • 1. Antihypertensive activity of a propranolol analog (ORF 12,592) in rodents.
    Ram N; Heilman RD; Greenslade FC
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):102-8. PubMed ID: 1015906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nylidrin: a potent anti-hypertensive agent in hypertensive rats.
    Yen TT; Pearson DV
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):11-28. PubMed ID: 441505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antihypertensive effects of propranolol and metoprolol in DOC-treated rats.
    Wendt RL; Much DR; Bergey JL; Wicks TC
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):110-20. PubMed ID: 7325751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.
    Ram N; Bauer EW; Hesse UC; Heilman RD
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):118-25. PubMed ID: 921395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged administration of indenolol in hypertensive rats.
    Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in DOCA hypertensive rats: development of hypertension inhibited and pressor responsiveness enhanced.
    Buñag RD
    Eur J Pharmacol; 1977 Jun; 43(4):323-31. PubMed ID: 880980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F; Clozel JP; Osterrieder W
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central antihypertensive activity of propranolol.
    Zawoiski EJ
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):111-31. PubMed ID: 7387254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats.
    Farsang C; Ramirez-Gonzalez MD; Tchakarov L; Kunos G
    Acta Physiol Hung; 1983; 62(2):167-75. PubMed ID: 6670566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical relationship between the superior cervical ganglia and the antihypertensive action of propranolol in the spontaneous hypertensive rat.
    Tuttle R; Elias B; McCleary M; Endy T
    J Pharmacol Exp Ther; 1982 Dec; 223(3):824-33. PubMed ID: 7143243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clonidine and propranolol on venous smooth muscle from spontaneously hypertensive rats.
    Greenberg S; Wilborn W
    Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):234-59. PubMed ID: 7138149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y; Nakahara H; Miyagishi A; Nakatani H
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by propranolol of exercise training effects in spontaneously hypertensive rats.
    Ghaemmaghami F; Gauquelin G; Allevard AM; Desplanches D; Favier R; Augoyard G; Gharib C
    J Hypertens; 1987 Aug; 5(4):445-9. PubMed ID: 3668246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.